IL-33 signaling in sensory neurons promotes dry skin itch

Anna M. Trier(Washington University in St. Louis), Madison R. Mack(Washington University in St. Louis), Avery Fredman(Washington University in St. Louis), Masato Tamari(Washington University in St. Louis), Aaron Ver Heul(Washington University in St. Louis), Yonghui Zhao(Washington University in St. Louis), Changxiong Guo(Washington University in St. Louis), Oshri Avraham(Washington University in St. Louis), Zachary K. Ford(University of Cincinnati Medical Center), Landon K. Oetjen(Washington University in St. Louis), Jing Feng(Washington University in St. Louis), Carina Dehner(Washington University in St. Louis), Dean W. Coble(Washington University in St. Louis), Asima Badic(Washington University in St. Louis), Satoru Joshita(Shinshu University), Masato Kubo(RIKEN Center for Integrative Medical Sciences), Robert W. Gereau(Washington University in St. Louis), Jennifer Alexander‐Brett(Washington University in St. Louis), Valeria Cavalli(Washington University in St. Louis), Steve Davidson(University of Cincinnati Medical Center), Hongzhen Hu(Washington University in St. Louis), Qin Liu(Washington University in St. Louis), Brian Kim(Washington University in St. Louis)
Journal of Allergy and Clinical Immunology
September 21, 2021
Cited by 110Open Access
Full Text

Abstract

BACKGROUND: Chronic pruritus, or itch, is common and debilitating, but the neuroimmune mechanisms that drive chronic itch are only starting to be elucidated. Recent studies demonstrate that the IL-33 receptor (IL-33R) is expressed by sensory neurons. However, whether sensory neuron-restricted activity of IL-33 is necessary for chronic itch remains poorly understood. OBJECTIVES: We sought to determine if IL-33 signaling in sensory neurons is critical for the development of chronic itch in 2 divergent pruritic disease models. METHODS: Plasma levels of IL-33 were assessed in patients with atopic dermatitis (AD) and chronic pruritus of unknown origin (CPUO). Mice were generated to conditionally delete IL-33R from sensory neurons. The contribution of neuronal IL-33R signaling to chronic itch development was tested in mouse models that recapitulate key pathologic features of AD and CPUO, respectively. RESULTS: IL-33 was elevated in both AD and CPUO as well as their respective mouse models. While neuron-restricted IL-33R signaling was dispensable for itch in AD-like disease, it was required for the development of dry skin itch in a mouse model that mirrors key aspects of CPUO pathology. CONCLUSIONS: These data highlight how IL-33 may be a predominant mediator of itch in certain contexts, depending on the tissue microenvironment. Further, this study provides insight into future therapeutic strategies targeting the IL-33 pathway for chronic itch.


Related Papers